This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • DPP-4 Inhibition, Incretins and Islet Function (CO...
Clinical trial

DPP-4 Inhibition, Incretins and Islet Function (CODI24)

Read time: 1 mins
Last updated:14th Mar 2014

Hypothesis is that DPP-4 inhibition affects glucose levels through changes in incretin and islet hormones. The study examines this in relation to breakfast, lunch and dinner over an entire 24h study period by the use of three different DPP-4 inhibitors and placebo.

Category Value
Study start date 2014-03-14

View full details